
MicroLight Gene
微光基因
MicroLight Gene
Biotech/Healthcare
Founded in Suzhou in 2021, Weiguang Gene is focused on the R&D and commercialization of novel gene-editing technologies, using new gene-editing tools and cell and gene therapy methods as its foundation. Its team has extensive expertise in gene editing, protein science, aging, rare diseases, and…
Latest round: Pre Series A (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-09-09
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.